Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer.
No easy answers: European research consortia take on major challenges
GlobeNewswire, Inc.
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological...
Brilliant Earth Launches The Solstice Collection, a Limited-Edition Swiss Watch Collection and its First Entry into the Category
GlobeNewswire, Inc.
SAN FRANCISCO, July 09, 2026 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. ("Brilliant Earth" or the "Company") (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced the launch of The Solstice...
Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges
GlobeNewswire, Inc.
A new peer-reviewed study validates CellEDIT’s ability to overcome cell-editing barriers, uncovering dermokine’s pivotal role in wound healing and skin cancer biology.
SEALSQ and GlobalFoundries Partner to Accelerate Post-Quantum Cryptography and Quantum Computing Technologies
GlobeNewswire, Inc.
Geneva, Switzerland, July 08, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) ("SEALSQ") and GlobalFoundries (Nasdaq: GFS) (GF) today announced a strategic Memorandum of Understanding (MoU) to co-develop across secure semiconductor platforms,...
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
GlobeNewswire, Inc.
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials Dr. Ricordi to support advancement of NewcelX's Type 1 Diabetes program and...
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
GlobeNewswire, Inc.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...
Nepal 2035: A Policy Blueprint to Build the 'Switzerland of South Asia'
EIN Presswire
comprehensive study proposing institutional reform, economic transformation, and sustainable development to help Nepal become the “Switzerland of South Asia.” NEW YORK, NY, UNITED STATES, July 8, 2026 /EINPresswire.com/ -- 2510.org Releases...
Acronis Research and Development Wins Workforce Transformation Award at SGTech Industry Gala 2026
GlobeNewswire, Inc.
SINGAPORE, July 07, 2026 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced that Acronis Asia Research and Development Pte Ltd has been named the SME category winner of the Workforce Transformation...
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 6, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made substantial...
SEALSQ and Quobly Sign $5 Million Commercial Agreement to Integrate Post-Quantum Security into Next-Generation Silicon Quantum Computing Platforms
GlobeNewswire, Inc.
Geneva, Switzerland & Grenoble, France, July 10, 2026 (GLOBE NEWSWIRE) -- Agreement Marks the Commercialization Phase of the Strategic Collaboration Between SEALSQ and Quobly and Advances the Development of Secure, Sovereign and Scalable Quantum...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer
GlobeNewswire, Inc.
BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GlobeNewswire, Inc.
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technology Focuses on patients at highest risk, including those with...
Secro Appoints Guy de Pourtalès As Chief Technology Officer
EIN Presswire
Strengthening SECRO’s bank-grade digital infrastructure, scalability, and AI roadmap for global trade finance documentation GENEVA, SWITZERLAND, July 1, 2026 /EINPresswire.com/ -- SECRO, the trade finance tokenization and document workflow...
Parametric Insurance Market to Reach $34.4 Billion Globally by 2033, Growing at 6.6% CAGR | Allied Market Research
EIN Presswire
Rising Climate Risks, Rapid Claims Processing, AI-Driven Risk Modeling, and Expanding Alternative Risk Transfer Solutions Accelerate Global Market Growth WILMINGTON, DE, UNITED STATES, July 1, 2026 /EINPresswire.com/ -- According to a new report...
Natural Embrace™ Introduces Made in USA High-Tech Skincare for Sensitive Skin
EIN Presswire
LOS ANGELES, CA, UNITED STATES, June 30, 2026 /EINPresswire.com/ -- Natural Embrace™, a USA-based skincare company focused on advanced skin science and natural ingredients, is pleased to announce the introduction of its Made in USA skincare and...
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
GlobeNewswire, Inc.
PRESS RELEASE AB SCIENCE REPORTS COMPLETION OF THE STEP 3 OF PHASE 1, EVALUATING THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 WITH VENETOCLAX GENERATED A 67%...
Switzerland ERP Industry Expands at 11.0% CAGR, Eyeing $1,272.14 Million by 2030 | AMR
EIN Presswire
WILMINGTON, NEW CASTLE, DE, UNITED STATES, June 24, 2026 /EINPresswire.com/ -- According to a recent report published by Allied Market Research, titled, "Switzerland ERP Market by Component, deployment model, business function, end user and...
Beauty&Longevity CHOICE Awards 2027 Open for Entries, Putting Science-Led Beauty & Longevity Innovation in the Spotlight
EIN Presswire
19 categories across four pillars—from skin longevity and metabolic health to diagnostics, devices and biotech.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.